Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024


-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History ---- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million --

More:
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

Related Posts